Vanberra Signal

Celine Therapeutics

Curated by Signal

Provider of AI interfaced protein synthesis therapies through automation and computation

Overview

Provider of AI interfaced protein synthesis therapies through automation and computation. The platform is an end to end system that integrates various technologies to manage discovery, development, and manufacturing of cell therapies. It allows users in identification of potential drug targets and compounds, and offers tools to analyze data and design therapies. It works in synthetic biology tehcnology that enables the engineering of living organisms to produce therapeutic outcomes and uses computational methods to predict and design novel proteins with specific functions and properties.

Key facts

Founded
2022
Headquarters
United States

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of devices for remote patient monitoring

    Life Sciences TechnologyIrvine, United States
  • Provider of computational tools for metabolic engineering

    Life Sciences TechnologySaint Paul, United States

About Celine Therapeutics

What does Celine Therapeutics do?

Provider of AI interfaced protein synthesis therapies through automation and computation.

Where is Celine Therapeutics headquartered?

Celine Therapeutics is headquartered in United States.

When was Celine Therapeutics founded?

Celine Therapeutics was founded in 2022.

Which sector is Celine Therapeutics in?

Celine Therapeutics operates in Life Sciences Technology.

Who are Celine Therapeutics's competitors?

Companies similar to Celine Therapeutics include Lotus Health, Molecular Targeting Technology, and Genome Craft.